Literature DB >> 1837650

Parkinson's disease occurrence in Europe.

J de Pedro-Cuesta1.   

Abstract

Parkinson's disease (PD) surveys and death-record studies in European populations were reviewed. Particular attention was given to methodological aspects. Two sets of quality criteria were used. Four door-to-door surveys revealed underdiagnosis of prevalent idiopathic parkinsonism ranging from 30% to 71%. Quality surveys based on medical records were scarce. The analysis of a) the time relationships between the diagnostic process and the study period for measurements, and b) a variation observed in the shape of the curve for age-specific prevalences, suggested that both incidence and prevalence were underestimated by these surveys, especially among the elderly. In the UK, Denmark and Sweden, mortality from parkinsonism increased over time for ages over 70 years, but decreased for the younger age groups. A two-fold variation in mortality was found between countries. It is concluded that PD is widely distributed in Europe, and that most geographical differences in reported disease occurrence can be explained by methodological variations in measurements. The pattern of variation of age-specific figures was similar for mortality and prevalence. This might reflect decreasing prevalences among those aged under 70 years and increasing ascertainment in the elderly. There is a need for research methods for specific purposes in this field to be developed.

Entities:  

Mesh:

Year:  1991        PMID: 1837650     DOI: 10.1111/j.1600-0404.1991.tb04969.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

1.  Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniques.

Authors:  Mark J C Nuijten; Frans Rutten
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

2.  Essential tremor might be less frequent than Parkinson's disease in North Israel Arab villages.

Authors:  Amir Glik; Magdalena Masarwa; Amin Abuful; Amar Deeb; Rosa Strugatsky; Lindsay A Farrer; Robert P Friedland; Rivka Inzelberg
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

3.  The prevalence of Parkinson's disease in Portugal. A population approach.

Authors:  J A Dias; M M Felgueiras; J P Sanchez; J M Gonçalves; J M Falcäo; Z P Pimenta
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

4.  Essential Tremor Prevalence is Low in the Druze Population in Northern Israel.

Authors:  Judith Aharon-Peretz; Samih Badarny; Raphiq Ibrahim; Ruth Gershoni-Baruch; Gamal Hassoun
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-03-22

5.  Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007.

Authors:  Jeff Bronstein; Paul Carvey; Honglei Chen; Deborah Cory-Slechta; Donato DiMonte; John Duda; Paul English; Samuel Goldman; Stephen Grate; Johnni Hansen; Jane Hoppin; Sarah Jewell; Freya Kamel; Walter Koroshetz; James W Langston; Giancarlo Logroscino; Lorene Nelson; Bernard Ravina; Walter Rocca; George W Ross; Ted Schettler; Michael Schwarzschild; Bill Scott; Richard Seegal; Andrew Singleton; Kyle Steenland; Caroline M Tanner; Stephen Van Den Eeden; Marc Weisskopf
Journal:  Environ Health Perspect       Date:  2008-08-26       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.